Oslo, October 22, 2003

Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first 9 months of 2003 was NOK 8.5 million compared to a loss of NOK 47.4 million the same period last year. Total revenues were NOK 10.1 million including other operating income of NOK 4.4 million, down from NOK 40.5 million in the same period of 2002.

DOWNLOADS:
Q3 Results (130 kB Word)Q3 Presentation (590 kB PowerPoint)

Previous reports can be downloaded from the INVESTOR page.

 

Upcoming financial events 2003
 
February 4th, 2004  Presentation of Q4 2003
  
For further information, please contact
Eirik Uboe, CFO  +44 7766 051466